T1	Age 2 13	23-year-old
T2	Sex 14 19	woman
T3	Disease_disorder 38 58	carnitine deficiency
E1	Disease_disorder:T3 
T4	History 38 58	carnitine deficiency
T5	Sign_symptom 85 92	dyspnea
E2	Sign_symptom:T5 
T6	Sign_symptom 97 104	fatigue
E3	Sign_symptom:T6 
T7	Detailed_description 74 84	exertional
R1	MODIFY Arg1:T7 Arg2:E2	
T8	Disease_disorder 147 161	cardiomyopathy
E4	Disease_disorder:T8 
T9	Age 165 177	age 10 years
T10	Detailed_description 135 146	nonischemic
R2	MODIFY Arg1:T10 Arg2:E4	
T11	Disease_disorder 226 239	heart failure
E5	Disease_disorder:T11 
T12	Detailed_description 215 225	congestive
R3	MODIFY Arg1:T12 Arg2:E5	
T13	Diagnostic_procedure 244 274	transthoracic echocardiography
E6	Diagnostic_procedure:T13 
T14	Diagnostic_procedure 276 279	TTE
E7	Diagnostic_procedure:T14 
R4	IDENTICAL Arg1:E7 Arg2:E6	
T16	Disease_disorder 315 317;319 330	LV dysfunction
E8	Disease_disorder:T16 
T15	Disease_disorder 297 313;319 330	left ventricular dysfunction
E9	Disease_disorder:T15 
R5	IDENTICAL Arg1:E8 Arg2:E9	
T17	Severity 290 296	severe
R6	MODIFY Arg1:T17 Arg2:E9	
R7	MODIFY Arg1:E9 Arg2:E7	
T18	Sign_symptom 203 211	symptoms
E10	Sign_symptom:T18 
R8	MODIFY Arg1:E5 Arg2:E10	
T19	Diagnostic_procedure 350 371	total carnitine level
E11	Diagnostic_procedure:T19 
T20	Lab_value 376 385	<3 μmol/L
R9	MODIFY Arg1:T20 Arg2:E11	
T21	Diagnostic_procedure 424 444	free carnitine level
E12	Diagnostic_procedure:T21 
T22	Lab_value 449 458	<3 μmol/L
R10	MODIFY Arg1:T22 Arg2:E12	
*	OVERLAP E11 E8 E12 E15
*	OVERLAP E5 E6
T23	Date 165 177	age 10 years
E13	Date:T23 
*	OVERLAP E13 E10 E4
T24	Disease_disorder 526 546	carnitine deficiency
E14	Disease_disorder:T24 
T25	Disease_disorder 493 507	cardiomyopathy
E15	Disease_disorder:T25 
R11	CAUSE Arg1:E14 Arg2:E15	
T26	Duration 554 562	5 months
E16	Duration:T26 
T27	Medication 579 600	carnitine supplements
E17	Medication:T27 
*	OVERLAP E16 E17
T28	Diagnostic_procedure 606 621;641 647	total carnitine levels
E18	Diagnostic_procedure:T28 
T29	Diagnostic_procedure 626 647	free carnitine levels
E19	Diagnostic_procedure:T29 
T30	Lab_value 665 674	86 μmol/L
T31	Lab_value 679 688	48 μmol/L
R12	MODIFY Arg1:T30 Arg2:E18	
R13	MODIFY Arg1:T31 Arg2:E19	
T32	Diagnostic_procedure 729 746	systolic function
E20	Diagnostic_procedure:T32 
T33	Biological_structure 712 728	left ventricular
R14	MODIFY Arg1:T33 Arg2:E20	
T34	Lab_value 793 798	34.7%
T35	Medication 929 957	carnitine supplement regimen
E21	Medication:T35 
T36	Detailed_description 895 919	intermittently compliant
R15	MODIFY Arg1:T36 Arg2:E21	
T37	Date 983 1011	6 months before presentation
E22	Date:T37 
T38	Diagnostic_procedure 1037 1051	free carnitine
E23	Diagnostic_procedure:T38 
T39	Diagnostic_procedure 1017 1032	total carnitine
E24	Diagnostic_procedure:T39 
T40	Lab_value 1074 1083	18 μmol/L
T41	Lab_value 1088 1097	17 μmol/L
R16	MODIFY Arg1:T40 Arg2:E24	
R17	MODIFY Arg1:T41 Arg2:E24	
T42	Diagnostic_procedure 768 789	fractional shortening
E25	Diagnostic_procedure:T42 
T43	Lab_value 751 761	normalized
R19	BEFORE Arg1:E17 Arg2:E18	
*	OVERLAP E18 E19 E20
R20	SUB_PROCEDURE Arg1:E25 Arg2:E20	
R21	MODIFY Arg1:T43 Arg2:E20	
R22	MODIFY Arg1:T34 Arg2:E25	
T44	Duration 853 875	over the past 10 years
E26	Duration:T44 
*	OVERLAP E26 E21
T46	Clinical_event 815 824	admission
E28	Clinical_event:T46 
T47	Diagnostic_procedure 1127 1130	TTE
E29	Diagnostic_procedure:T47 
T48	Diagnostic_procedure 1143 1169	cardiac magnetic resonance
E30	Diagnostic_procedure:T48 
T49	Diagnostic_procedure 1171 1174	CMR
E31	Diagnostic_procedure:T49 
R23	IDENTICAL Arg1:E31 Arg2:E30	
R25	BEFORE Arg1:E29 Arg2:E30	
T51	Diagnostic_procedure 1227 1238	LV function
E32	Diagnostic_procedure:T51 
T52	Diagnostic_procedure 1209 1212	TTE
E33	Diagnostic_procedure:T52 
T53	Lab_value 1220 1226	normal
R26	MODIFY Arg1:T53 Arg2:E32	
R27	SUB_PROCEDURE Arg1:E32 Arg2:E33	
T54	Disease_disorder 1260 1274	LV hypertrophy
E34	Disease_disorder:T54 
T55	Detailed_description 1249 1259	concentric
T56	Severity 1243 1247	mild
R28	MODIFY Arg1:T56 Arg2:E34	
R29	MODIFY Arg1:T55 Arg2:E34	
R30	MODIFY Arg1:E34 Arg2:E33	
T57	Diagnostic_procedure 1316 1323	LV size
E35	Diagnostic_procedure:T57 
T58	Lab_value 1309 1315	normal
R32	MODIFY Arg1:T58 Arg2:E35	
T59	Diagnostic_procedure 1316 1318;1328 1336	LV function
E36	Diagnostic_procedure:T59 
*	OVERLAP E36 E35 E37
R33	MODIFY Arg1:T58 Arg2:E36	
T60	Diagnostic_procedure 1364 1378	wall thickness
E37	Diagnostic_procedure:T60 
T61	Lab_value 1354 1363	increased
R34	MODIFY Arg1:T61 Arg2:E37	
T63	Biological_structure 1386 1412	basal and mid lateral wall
R36	MODIFY Arg1:T63 Arg2:E37	
T64	Diagnostic_procedure 1414 1437	end-diastolic thickness
E38	Diagnostic_procedure:T64 
T65	Distance 1439 1445	1.6 cm
R37	MODIFY Arg1:T65 Arg2:E38	
T66	Diagnostic_procedure 1467 1497	delayed gadolinium enhancement
E39	Diagnostic_procedure:T66 
T68	Family_history 1555 1575	sudden cardiac death
T71	Family_history 1577 1606	abnormal myocardial structure
T73	Family_history 1612 1638	underlying disease process
T74	Therapeutic_procedure 1655 1693	implantable cardioverter-defibrillator
E43	Therapeutic_procedure:T74 
T75	Detailed_description 1642 1654	dual-chamber
R39	MODIFY Arg1:T75 Arg2:E43	
T50	Diagnostic_procedure 1181 1203	gadolinium enhancement
E44	Diagnostic_procedure:T50 
R24	SUB_PROCEDURE Arg1:E44 Arg2:E31	
R40	AFTER Arg1:E28 Arg2:E26	
R41	BEFORE Arg1:E21 Arg2:E22	
*	OVERLAP E22 E24 E23
R42	BEFORE Arg1:E24 Arg2:E29	
T76	History 135 161	nonischemic cardiomyopathy
T77	History 203 211	symptoms
T78	History 215 239	congestive heart failure
T79	History 244 274	transthoracic echocardiography
T80	History 290 330	severe left ventricular (LV) dysfunction
T81	History 350 371	total carnitine level
T82	History 424 444	free carnitine level
*	OVERLAP E2 E3
T83	History 493 507	cardiomyopathy
T84	History 526 546	carnitine deficiency
R18	BEFORE Arg1:E14 Arg2:E16	
T85	History 579 600	carnitine supplements
T86	History 606 621;641 647	total carnitine levels
T87	History 626 647	free carnitine levels
T88	History 712 746	left ventricular systolic function
T89	History 768 789	fractional shortening
T90	Detailed_description 1348 1353	focal
R43	MODIFY Arg1:T90 Arg2:E37	
R44	BEFORE Arg1:E25 Arg2:E28	
T45	Diagnostic_procedure 1295 1298	CMR
E27	Diagnostic_procedure:T45 
#1	AnnotatorNotes E33	Should label as coreference if referring to previously mentioned TTE?
R31	AFTER Arg1:E44 Arg2:E33	
*	OVERLAP E33 E29
R45	BEFORE Arg1:E33 Arg2:E27	
*	OVERLAP E27 E31
#2	AnnotatorNotes E27	Should label as coreference if refer to previous CMR?
R46	SUB_PROCEDURE Arg1:E36 Arg2:E27	
R47	SUB_PROCEDURE Arg1:E35 Arg2:E27	
R48	SUB_PROCEDURE Arg1:E37 Arg2:E27	
R49	SUB_PROCEDURE Arg1:E38 Arg2:E37	
T91	Detailed_description 1460 1466	patchy
R50	MODIFY Arg1:T91 Arg2:E39	
R51	SUB_PROCEDURE Arg1:E39 Arg2:E37	
R53	BEFORE Arg1:E1 Arg2:E2	
T92	Disease_disorder 1731 1751	sudden cardiac death
E45	Disease_disorder:T92 
A1	POLARITY E45 NEG
R38	BEFORE Arg1:E39 Arg2:E43	
R52	BEFORE Arg1:E43 Arg2:E45	
T67	Sign_symptom 1762 1778	bradyarrhythmias
E40	Sign_symptom:T67 
T69	Sign_symptom 1783 1799	tachyarrhythmias
E41	Sign_symptom:T69 
A2	POLARITY E40 UNCERTAIN
A3	POLARITY E41 UNCERTAIN
*	OVERLAP E45 E40 E41
